# Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis

> **NCT00297011** · PHASE2 · COMPLETED · sponsor: **University of Utah** · enrollment: 300 (—)

## Conditions studied

- Herpes Labialis

## Interventions

- **DRUG:** valacyclovir+clobetasol gel

## Key facts

- **NCT ID:** NCT00297011
- **Lead sponsor:** University of Utah
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** 2007-03
- **Final completion:** 2008-01
- **Target enrollment:** 300 (—)
- **Last updated:** 2008-05-06

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00297011

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00297011, "Valacyclovir+Temovate Gel for the Treatment of Herpes Labialis". Retrieved via AI Analytics 2026-08-17 from https://api.ai-analytics.org/clinical/NCT00297011. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*